22 results on '"Yoon, Dok-Hyun"'
Search Results
2. Electrophysiologic features of POEMS syndrome compared with MGUS‐related neuropathy
3. RGS1 expression is associated with poor prognosis in multiple myeloma
4. TCL1 expression predicts overall survival in patients with mantle cell lymphoma
5. Insulin-like growth factor-1 receptor is associated with better prognosis in classical Hodgkinʼs lymphoma: Correlation with MET expression
6. Phase 2 Study of Dovitinib in Patients With Metastatic or Unresectable Adenoid Cystic Carcinoma
7. Should the cut-off values of the lymphocyte to monocyte ratio for prediction of prognosis in diffuse large B-cell lymphoma be changed in elderly patients?
8. Role of surgical resection in complete responders on FDG-PET after chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
9. Remobilization of hematopoietic stem cells with high-dose methotrexate and cytarabine in patients with non-Hodgkinʼs lymphoma and multiple myeloma after failure to mobilize with chemotherapy and cytokines
10. Receptor tyrosine kinases MET and RON as prognostic factors in diffuse large B-cell lymphoma patients receiving R-CHOP
11. Subtle CD20 positivity in the bone marrow of a patient who has a mucosa-associated lymphoid tissue lymphoma should not be regarded as evidence of involvement in the bone marrow
12. Increment of hematopoietic progenitor cell count as an indicator of efficient autologs stem cell harvest in patients with multiple myeloma
13. Clinical features and prognostic model for extranasal NK/T-cell lymphoma
14. CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma
15. Sunitinib as a second-line therapy for advanced GISTs after failure of imatinib: relationship between efficacy and tumor genotype in Korean patients
16. Clinical features and outcomes of Hodgkinʼs lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL)
17. Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP
18. A phase I study of S-1 treatment with a 3 week schedule in advanced biliary cancer patients with or without hepatic dysfunction
19. Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP
20. Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation
21. S-1 plus cisplatin: another option in the treatment of advanced head and neck cancer?
22. Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkinʼs lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.